Stenotrophomonas maltophilia bacteremia and pneumonia at a tertiary-care oncology center: a review of 16 years
- 340 Downloads
The aim of this study was to describe the clinical characteristics and antimicrobial patterns of Stenotrophomonas maltophilia bloodstream infections (BSI) and pneumonia episodes in patients with cancer.
Patients with S. maltophilia BSI or pneumonia admitted from 1 Jan. 2000 to 31 Dec. 2016 were identified at the Instituto Nacional de Cancerología (INCan), a tertiary-care oncology hospital in Mexico City.
During the study period, there were 171 isolates identified. The mean age of the whole group was 46.9 ± 17.4 years; 99 (57.9%) were women. There were 95 BSI: 64 ambulatory catheter-related BSI (CRBSI), 20 nosocomial CRBSI, and 11 secondary BSI. Mortality was higher in nosocomial CRBSI (40%) vs. that in ambulatory CRBSI (7.8%) (p = 0.001). There were 76 pneumonia episodes; all were nosocomial acquired; 46 (60.5%) ventilator-associated. From all the group, nine strains (5.2%) were resistant to sulfamethoxazole/trimethoprim/(SMX/TMP). At the first month, 54 patients (31.6%) have died, 38 due to pneumonia (70%) and 16 due to BSI (30%, p < 0.001). Multivariate analysis showed that removal of central venous catheter was associated with a favorable outcome in patients with bacteremia. For patients with pneumonia, age ≥ 65 years and inappropriate antimicrobial treatment were risk factors associated with 30-day mortality.
S. maltophilia related with ambulatory CRBSI have a better prognosis than other sources of BSI. Older patients with pneumonia who do not receive appropriate antibiotics have higher mortality. SMX/TMP is still the antibiotic of choice.
KeywordsStenotrophomonas maltophilia Bloodstream infection Pneumonia Mortality Bacterial resistance
We thank the Microbiology Laboratory personnel who are responsible for processing all culture specimens at INCan, Mexico City.
Compliance with ethical standards
The study was approved by the Institutional Review Board (INCAN/Rev/10/17).
Conflict of interest
The authors declare that they have no conflict of interest.
- 2.Chang YT, Lin CY, PL L, Lai CC, Chen TC, Chen CY, DC W, Wang TP, Lin CM, Lin WR, Chen YH (2014) Stenotrophomonas maltophilia bloodstream infection: comparison between community-onset and hospital-acquired infections. J Microbiol Immunol Infect 47(1):28–35. https://doi.org/10.1016/j.jmii.2012.08.014 CrossRefPubMedGoogle Scholar
- 5.Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49(1):1–45. https://doi.org/10.1086/599376. CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Volkow P, Sandoval S, Campos AM, Gutiérrez M, de Romero C, Viana Aguiluz JJ, Perez Padilla JR (2006) Increase in catheter insertion-site infections associated to the introduction of a substandard competitive antiseptic. Am J Infect Control 34(6):335–337. https://doi.org/10.1016/j.ajic.2005.10.011 CrossRefPubMedGoogle Scholar
- 13.Wang CH, Lin JC, Lin HA, Chang FY, Wang NC, Chiu SK, Lin TY, Yang YS, Kan LP, Yang CH, Chan MC, Yeh KM (2016) Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: a 10-year retrospective study. J Microbiol Immunol Infect 49(3):378–386. https://doi.org/10.1016/j.jmii.2014.06.005 CrossRefPubMedGoogle Scholar